However, there are key differences in the studies that make a 1:1 comparison difficult. For one, the patients in the RESHAPE-HF2 trial had less severe mitral valve regurgitation than did those in the ...
I firmly believe you might like it better than Windows. I firmly believe you might like it better than Windows. Sean Hollister is a senior editor and founding member of The Verge who covers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback